Resolve specializes in molecular cartography technology that allows researchers to view subcellular biology. The company’s platform is used by Stanford (Calif.) Medicine’s Department of Genetics, according to an Oct. 24 Resolve news release.
Resolve’s latest funding round brings the company’s total capital raised to more than $100 million. The company plans to use its series B capital to scale operations and accelerate product development.
The funding round was led by Patient Square Capital.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
